Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease TreatmentJiewen Wang, Ario de Marco, Guangbo Kang et al.|Frontiers in Immunology|2022Cited by 84
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapiesZelin Feng, Xiaocang Cao, Guangbo Kang et al.|Biomedicine & Pharmacotherapy|2022Cited by 39
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivitiesJiewen Wang, He Huang, Guangbo Kang et al.|Clinical and Translational Medicine|2024Cited by 13